动态CT的参数反应映射:增强对经动脉化疗栓塞治疗的肝细胞癌患者生存的预测
本研究纳入65例接受经动脉化疗栓塞(TACE)的肝细胞癌患者,在TACE前后进行纵向多期CT检查,应用参数反应映射(PRM)分析将患者分为应答组与非应答组。PRM分析显示应答组中位生存529天,非应答组263天(HR 12.9,p<0.05);常规放射学评估手动分析对应中位生存491天与329天(HR 2.7,p<0.05)。结论认为PRM分析可能比常规放射学评估更好地预测接受TACE的HCC患者的总生存。
要点
- PRM分析将TACE患者分为应答组与非应答组,中位生存529天 vs 263天(HR 12.9,p<0.05)。
- 常规放射学手动分析对应中位生存491天 vs 329天(HR 2.7,p<0.05)。
- 肿瘤大小、白蛋白水平及PRM值与总生存显著相关。
核心结论
- PRM分析可能比常规放射学评估更好地预测接受TACE的HCC患者的总生存。
研究设计与样本
- 纳入65例接受TACE的HCC患者,行TACE前后纵向多期CT检查,对TACE前基线CT及第一/二次随访CT进行PRM分析,将患者分为应答组与非应答组,并与常规放射学评估的独立生存分析结果比较。
诊断标准与关键数值
- PRM分析应答组中位生存529天 vs 非应答组263天(HR 12.9,p<0.05)。常规放射学手动分析应答组中位生存491天 vs 非应答组329天(HR 2.7,p<0.05)。
临床应用与阅片要点
- 作者认为PRM分析可能比常规放射学评估更好地预测接受TACE的HCC患者的总生存。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: The aim of this study was to evaluate the prognostic significance of parametric response mapping (PRM) analysis for hepatocellular carcinoma (HCC) patients undergoing transarterial chemoembolization (TACE).
METHODS: We recruited 65 HCC patients who underwent TACE. These patients underwent longitudinal multiphasic CT before and after TACE. We applied PRM analysis to the baseline CT before TACE and first/second follow-up CTs. The results of PRM analyses were used to stratify patients into responders and non-responders. Overall survival was compared between the two groups. An independent survival analysis using conventional radiological assessments was performed, and the results were compared with PRM results. Univariate and multivariate analyses were performed to identify clinical factors affecting survival.
RESULTS: The PRM analyses demonstrated that the responding group had a median survival of 529 days, while the non-responding group had a median survival of 263 days [hazard ratio (HR) 12.9, p < 0.05 for differences in survival]. The manual analyses indicated median survivals of 491 and 329 days for the responding and non-responding groups, respectively (HR 2.7, p < 0.05). Tumor size, albumin level, and PRM values were found to be significantly related to overall survival after univariate and multivariate analyses.
CONCLUSIONS: The PRM analysis could be a better predictor of overall survival for patients with HCC undergoing TACE than conventional radiological assessments.
引用
- Choi SJ, Kim J, Kim HS, et al. Parametric response mapping of dynamic CT: enhanced prediction of survival in hepatocellular carcinoma patients treated with transarterial chemoembolization. Abdom Radiol (NY). 2017. PMID: 28204855. doi:10.1007/s00261-017-1082-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。